For possible Bacillus cereus contamination, atovaquone oral suspension, USP 750mg/5mL was voluntarily recalled.

Published Date: 06 Apr 2023

Atovaquone oral suspension, USP 750mg/5mL has been voluntarily recalled by Camber Pharmaceuticals Inc. due to worries about potential Bacillus cereus contamination.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Doctors say lung cancer is still the deadliest cancer, but hope is growing

2.

Child Death Rates Are Rising in the U. s. ; Water Beads Warning; Cancer Studies Retracted.

3.

FDA Leaders Explain Their Choice Regarding Cancer Risk Warning in CAR-T Investigation.

4.

The FDA has approved momelotinib for use in myelofibrosis patients who also have anemia.

5.

Virtual Reality Travel Reduces Cancer Pain.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot